Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-06

Clinical Trial Update: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ivermectin gel 0.1% plus metronidazole 1% for chronic blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ivermectin gel 0.1% plus metronidazole 1% (ivermectin + metronidazole)

Snippet

Sponsor: Universidad Nacional de Colombia | Conditions: Chronic Blepharitis | Phase 3 | Status: COMPLETED